The U.S. Chamber of Commerce has filed a lawsuit against the Department of Health and Human Services and Centers for Medicare & Medicaid Services in federal court, challenging the constitutionality of the Inflation Reduction Act’s drug price negotiation program. The lawsuit claims that the IRA violates the Constitution's "requirements of limited government, property rights, the rule of law, and separation of powers," giving too much control to the executive branch over drug pricing. The business group argues that the law would harm innovation and reduce access to drugs for patients. Other pharmaceutical companies are also considering legal action following Merck's similar lawsuit seeking to overturn drug pricing measures in the law. The legal challenges come as the Biden administration is pushing for drug pricing reform, proposing allowing Medicare to negotiate drug prices directly with manufacturers, which has been met with opposition from pharma industry leaders who believe it violates their constitutional rights.
Keywords: U.S. Chamber of Commerce, lawsuit, Inflation Reduction Act, drug price negotiation program, Constitutionality
The U.S. Chamber of Commerce has joined Merck in filing a lawsuit against the Department of Health and Human Services and Centers for Medicare & Medicaid Services regarding the Inflation Reduction Act’s drug price negotiation program. The suit claims that this act gives too much power to executives over drug pricing and